Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|June 4, 1999
Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compoundN Furukawa, T Ohta, T Noguchi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|January 14, 1998
Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in ratsM Matsushita, M Masaki, Y Yagi, et al.
Japanese Journal of Pharmacology|May 1, 1992
Inhibitory effect of OP-41483.alpha-CD, a prostacyclin analog, on peripheral vascular lesion models in ratsK Wakitani, T Takakuwa, M Sugioka, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 15, 2002
Prophylactic effect of JTE-607 on LPS-induced acute lung injury in rats with CINC-1 inhibitionH Iwamura, K Inushima, K Takeuchi, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 24, 1999
JTE-607, a novel inflammatory cytokine synthesis inhibitor without immunosuppression, protects from endotoxin shock in miceM Kakutani, K Takeuchi, I Waga, et al.
British Journal of Pharmacology|May 14, 1999
JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki ratsT Ohta, N Furukawa, G Komuro, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1985
Vasodilator properties of a family of bioactive atrial peptides in isolated perfused rat kidneysK Wakitani, M G Currie, D M Geller, et al.
Nature|July 26, 2000
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbitsH Okamoto, F Yonemori, K Wakitani, et al.
European Journal of Pharmacology|February 5, 1999
Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivativeT Shibata, K Matsui, K Nagao, et al.
Pageof 3